Role of myofibroblasts during normal tissue repair and excessive scarring: Interest of their assessment in nephropathies

Histology and Histopathology

Volumn 15, Issue 1, 2000, Pages 269-280

  Badid, C ^a   Mounier, N ^b   Costa, A M A ^c,d   Desmoulière, Alexis ^c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Smooth muscle actin; Cytoskeleton; Fibrosis; Kidney; Myofibroblast

Indexed keywords

ALPHA ACTIN; CYTOKINE;

CELL DIFFERENTIATION; CYTOSKELETON; DISEASE MARKER; EXTRACELLULAR MATRIX; FIBROSIS; GRANULATION TISSUE; HUMAN; KIDNEY DISEASE; KIDNEY INTERSTITIUM; MESANGIUM CELL; MYOFIBROBLAST; NONHUMAN; REVIEW; SCAR FORMATION; TISSUE REPAIR;

ANIMALS; CICATRIX; FIBROBLASTS; HUMANS; KIDNEY DISEASES; MUSCLE, SMOOTH; WOUND HEALING;

EID: 0033959028     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Akagi Y., Isaka Y., Aral M., Kaneko T., Takenaka M., Moriyama T., Kaneda Y., Ando A., Orita Y., Kamada T., Ueda N. and Imaï E. (1996). Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int. 50, 148-155.
2. Allen P.G., Shuster C.B., Kas J., Chaponnier C., Janmey P.A. and Herman I.M. (1996). Phalloidin binding and rheological differences among actin isoforms. Biochemistry 35, 14062-14069.
3. Alpers C.E., Hudkins K.L., Gown A.M. and Johnson R.J. (1992). Enhanced expression of "muscle specific" actin in glomerulonephritis. Kidney Int. 41, 1134-1142.
4. Andreutti D., Gabbiani G. and Neuville P. (1998). Early granulocytemacrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis. Lab. Invest. 78, 1493-1502.
5. Austin H.A., Boumpas D.T., Vaughan E.M. and Balow J.E. (1994). Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histological data. Kidney Int. 45, 544-550.
6. Badid C., Desmoulière A., McGrégor B., Costa A.M.A., Fouque D., Hadj-Aissa A. and Laville M. Interstitial α-smooth muscle actin: a prognostic marker in membranous nephropathy. Clin. Nephrol. 52, 210-217.
7. Baker A.J., Mooney A., Hughes J., Lombardy D., Johnson R.J. and Savill J. (1994). Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 94, 2105-2116.
8. Barrett T.B. and Benditt E.P. (1987). Sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc. Natl. Acad. Sci. USA 84, 1099-1103.
9. Baud L., Oudinet J.P., Bens M., Noe L., Peraldi M.N., Rondeau E., Etienne J. and Ardaillou R. (1989). Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int. 35, 1111-1118.
10. Benzonana G., Skalli O. and Gabbiani G. (1988). Correlation between the distribution of smooth muscle or nonmuscle myosins and α-smooth muscle actin in normal and pathological soft tissues. Cell Motil. Cytoskel. 11, 260-273.
11. Bochaton-Piallat M.L., Gabbiani F., Ropraz P. and Gabbiani G. (1992). Cultured aortic smooth muscle cells from newborn and adult rats show distinct cytoskeletal features. Differentiation 49, 175-185.
12. Bohle A., Muller G.A., Wehrmann M., Mackensen H. and Xiao J.C. (1996). Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies and chronic interstitial nephritides. Kidney Int. 49, S2-S9.
13. Border W.A., Noble N.A., Yamamoto T., Harper J.R., Yamaguchi Y., Pierschbacher M.D. and Ruoslahti E. (1992). Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360, 361-364.
14. Boukhalfa G., Desmoulière A., Rondeau E., Gabbiani G. and Sraer J.D. (1996). Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney. Exp. Nephrol. 4, 241-247.
15. Braden G., Rastegar A., Hession J., Garb J., Siegel N., Fitzgibbons J. and Kashgarian M. (1988). Predictors of progression to chronic renal failure in idiopathic membranous glomerulonephritis. Kidney Int. 33, 183 (Abstract).
16. Brown C.A., Zusman R.M. and Haber E. (1980). Identification of an angiotensin receptor in rabbit renomedullary interstitial cells in tissue culture. Correlation with prostaglandin biosynthesis. Circ. Res. 46, 802-807.
17. Brown L.F., Dubin D., Lavigne L., Logan B., Dvorak H.F. and Van De Water L. (1993). Macrophages and fibroblasts express embryogenic fibronectins during cutaneous wound healing. Am. J. Pathol. 142, 793-801.
18. Buckingham M.E., Alonso S., Barton P., Bugaisky G., Cohen A., Daubas P., Garner I., Minty A., Robert B. and Weydert A. (1984). Actin and myosin genes, and their expression during myogenesis in the mouse. In: Molecular biology of development. Davidson E.H. and Firtel R.A. (eds). Liss AR, New York, pp 275-292.
19. Buoro S., Ferrarese P., Chiavegato A., Roelofs M., Scatena M., Pauletto P., Passerini-Glazel G., Pagano F. and Sartore S. (1993). Myofibroblast-derived smooth muscle cells during remodelling of rabbit urinary bladder wall induced by partial outflow obstruction. Lab. Invest. 69, 589-602.
20. Cameron J.S. (1992). Membranous nephropathy-still a treatment dilemma. N. Engl. J. Med. 327, 638-639.
21. Cattran D.C., Pey Y., Greenwood C.M.T., Ponticelli C., Passerini P. and Honkanien E. (1997). Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney. Int. 51, 901-907.
22. Chiavegato A., Bochaton-Piallat M.L., D'Amore E., Sartore S. and Gabbiani G. (1995). Expression of myosin heavy chain isoforms in mammary epithelial cells and in myofibroblasts from different fibrotic settings during neoplasia. Virchows Arch. 426, 77-86.
23. Couchoud C., Laville M. and Boissel J.P. (1994). Treatment of membranous nephropathy: a meta-analysis. Nephrol. Dial. Transplant. 9, 469-470.
24. Darby I., Skalli O. and Gabbiani G. (1990). α-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 63, 21-29.
25. Desmoulière A. and Gabbiani G. (1995). Myofibroblast differentiation during fibrosis. Exp. Nephrol. 3, 134-139.
26. Desmoulière A. and Gabbiani G. (1996). The role of the myofibroblast in wound healing and fibrocontractive diseases. In: The molecular and cellular biology of wound repair. 2nd ed. Clark R.A.F. (ed). Plenum Press Corporation. New York. pp 391-423.
27. Desmoulière A., Rubbia-Brandt L., Abdiu A., Walz T., Macieira-Coelho A. and Gabbiani G. (1992a). α-Smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by γ-interferon. Exp. Cell Res. 201, 64-73.
28. Desmoulière A., Rubbia-Brandt L., Grau G. and Gabbiani G. (1992b). Heparin induces α-smooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts. Lab. Invest. 67, 716-726.
29. Desmoulière A., Geinoz A., Gabbiani F. and Gabbiani G. (1993). Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122, 103-111.
30. Desmoulière A., Redard M., Darby I. and Gabbiani G. (1995). Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146, 56-66.
31. Desmoulière A., Badid C., Bochaton-Piallat M.L. and Gabbiani G. (1997a). Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int. J. Biochem. Cell. Biol. 29, 19-30.
32. Desmoulière A., Darby I., Monte Alto Costa A., Raccurt M., Tuchweber B., Sommer P. and Gabbiani G. (1997b). Extracellular matrix deposition, lysyl oxydase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab. Invest. 76, 765-778.
33. Desmoulière A., Xu G., Costa A.M.A., Yousef I.M., Gabbiani G., Tuchweber B. (1999). Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells. J. Hepatol. 30, 621-631.
34. Eddy R.J., Petro J.A. and Tomasek J.J. (1988). Evidence for the nonmuscle nature of the "myofibroblast" of granulation tissue and hypertrophic scar. An immunofluorescence study. Am. J. Pathol. 130, 252-260.
35. Ehrenreich T. and Churg J. (1968). Pathology of membranous nephropathy. Pathol. Annu. 3, 145-186.
36. Elger M., Drenckhahn D., Nobiling R., Mundel P. and Kriz W. (1993). Cultured rat mesangial cells contain smooth muscle α-actin not found in vivo. Am. J. Pathol. 142, 497-509.
37. Essawy M., Soylemezoglu O., Muchaneta-Kubara E.C., Shortland J., Brown C.B. and El Nahas A.M. (1997). Myofibroblasts and the progression of diabetic nephropathy. Nephrol. Dial. Transplant. 12, 43-50.
38. Franke W.W., Schmid E., Osborn M. and Weber K. (1978). Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc. Natl. Acad. Sci. USA 75, 5034-5038.
39. Gabbiani G. (1992). The biology of the myofibroblast. Kidney. Int. 41, 530-532.
40. Gabbiani G. (1998). Evolution and clinical implications of the myofibroblast concept. Cardiovasc. Res. 38, 545-548.
41. Gabbiani G., Ryan G.B. and Majno G. (1971). Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27, 549-550.
42. Gard D.L., Bell P.B. and Lazarides E. (1979). Coexistence of desmin and the fibroblastic intermediate filament subunit in muscle and nonmuscle cells: identification and comparative peptide analysis. Proc. Natl. Acad. Sci. USA 76, 3894-3898.
43. Giuriato L., Scatena M., Chiavegato A., Tonello M., Scannapieco G., Pauletto P. and Sartore S. (1992). Non-muscle myosin isoforms and cell heterogeneity in developing rabbit vascular smooth muscle. J. Cell Sci. 101, 233-246.
44. Goumenos D.S., Brown C.B., Shortland J. and El Nahas A.M. (1994). Myofibroblasts, predictors of progression in IgA nephropathy. Nephrol. Dial. Transplant. 9, 1418-1425.
45. Gown A.M., Vogel A.M., Gordon D. and Lu P.L. (1985). A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J. Cell Biol. 100, 807-813.
46. Grinnell F. (1994). Fibroblasts, myofibroblasts and wound contraction. J. Cell. Biol. 124, 401-404.
47. Grupp C., Lottermoser J., Cohen D.I., Begher M., Franz H.E. and Müller G. (1997). Tranformation of rat inner medullary fibroblasts to myofibroblasts in vitro. Kidney Int. 52, 1279-1290.
48. Hall A. (1998). Rho GTPases and the actin cytoskeleton. Science 279, 509-514.
49. Hattori M., Horita S., Yoshioka T., Yamaguchi Y., Kawaguchi H. and Ito K. (1997). Mesangial phenotypic changes associated with cellular lesions in primary focal segmental glomerulosclerosis. Am. J. Kidney Dis. 30, 632-638.
50. Herman I. M. (1993). Actin isoforms. Curr. Opin. Cell Biol. 5, 48-55.
51. Horii Y., Muraguchi A., Iwano M., Matsuda T., Hirayama T., Yamada H., Fujii Y., Dohl K., Ishikawa H., Ohmoto Y., Yoshizaki K., Hirano T. and Kishimoto T. (1989). Involvement of IL-6 in mesangial proliferative glomerulonephritis. J. Immunol. 143, 3949-3955.
52. Jarnagin W.R., Rockey D.C., Koteliansky V.E., Wand S.S. and Bissell M. (1994). Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat heaptic fibrogenesis. J. Cell Biol. 127, 2037-2048.
53. Johnson R.J., Lida H., Alpers C.E., Majesky M.W., Schwartz S.M., Pritzl P., Gordon K. and Gown A.M. (1991). Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J. Clin. Invest. 87, 847-858.
54. Juliano R.L. and Haskill S. (1993). Signal transduction from the extracellular matrix. J. Cell Biol. 120, 577-585.
55. Kaissling B. and Le Hir M. (1994). Characterization and distribution of interstitial cell types in the renal cortex of rats. Kidney. Int. 45, 709-720.
56. Kocher O. and Gabbiani G. (1987). Analysis of α-smooth-muscle actin mRNA expression in rat aortic smooth-muscle cells using a specific cDNA probe. Differentiation 34, 201-209.
57. Kocher O., Skalli O., Bloom W.S. and Gabbiani G. (1984). Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab. Invest. 50, 645-652.
58. Komuro T. (1990). Re-evaluation of fibroblasts and fibroblast-like cells. Anat. Embryol. 182, 103-112.
59. Lemley K.V. and Kriz W. (1991). Anatomy of the renal interstitium. Kidney Int. 39, 370-381.
60. Loukianov E., Loukianova T. and Periasamy M. (1997). Myosin heavy chain isoforms in smooth muscle. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 117, 13-18.
61. Lovett D.H. and Sterzel R.B. (1986). Cell culture approaches to the analysis of glomerular inflammation. Kidney Int. 30, 246-254.
62. Machesky L.M. and Hall A. (1996). Rho: a connection between membrane receptor signalling and the cytoskeleton. Trends Cell Biol. 6, 304-310.
63. MacPherson B.R., Leslie K.O., Lizaso K.V. and Schwarz J.E. (1993). Contractile cells of the kidney in primary glomerular disorders: an immunohistochemical study using an anti-alpha-smooth muscle actin monoclonal antibody. Human Pathol. 24, 710-716.
64. Madsen C.S., Regan C.P., Hungerford J.E., White S.L., Manabe I. and Owens G.K. (1998). Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5′-flanking and first intronic DNA sequence. Circ. Res. 82, 908-917.
65. Mallat A., Preaux A.M., Blazejewski S., Rosenbaum J., Dhumeaux D. and Mavier P. (1995). Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 21, 1003-1010.
66. Manabe N., Chevallier M., Chossegros P., Causse X., Guerret S., Trépo C. and Grimaud J.A. (1993). Interferon-α2β therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation. Hepatology 18, 1344-1349.
67. Molitoris B.A. (1997). Putting the actin cytoskeleton into perspective: pathophysiology of ischemic alterations. Am. J. Physiol. 272, F430-F433.
68. Mounier N. and Sparrow J.C. (1997). Structural comparisons of muscle and non-muscle actins give insights into the evolution of their functional differences. J. Mol. Evol. 44, 89-97.
69. Mounier N., Desmoulière A. and Gabbiani G. (1999). Subcutaneous tissue fibroblasts transfected with muscle and nonmuscle actins: a good in vitro model to study fibroblastic cell plasticity. Wound Rep. Reg. 7, 45-52.
70. Mounier N., Perriard J.C., Gabbiani G. and Chaponnier C. (1997). Transfected muscle and non-muscle actins are differentially sorted by cultured smooth muscle and non-muscle cells. J. Cell Sci. 110, 839-846.
71. Muchaneta-Kubara E.C. and El Nahas A.M. (1997). Myofibroblast phenotype expression in experimental renal scarring. Nephrol. Dial. Transplant. 12, 904-915.
72. Murphy G. and Docherty A.J. (1992). The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell. Mol. Biol. 7, 120-125.
73. Nath K.A. (1992). Tubulointerstitial disease as a major determinant of progressive renal injury. Am. J. Kidney Dis. 20, 1-17.
74. Ng Y.Y., Huang T.P., Yang W.C., Chen Z.P., Yang A.H., Mu W., Nikolic-Paterson D.J., Atkins R.C. and Lan H.Y. (1998). Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int. 54, 864-876.
75. Norman J.T. and Lewis M.P. (1996). Matrix metalloproteinases (MMPs) in renal fibrosis. Kidney Int. 49, S61-S63.
76. North A.J., Gimona M., Lando Z. and Small J.V. (1994). Actin isoform compartments in chicken gizzard smooth muscle cells. J. Cell Sci. 107, 445-455.
77. Okada H., Strutz F., Danoff T. and Neilson E.G. (1996). Possible pathogenesis in renal fibrosis. Kidney Int. 49, S37-S39.
78. Osborn M., Caselitz J. and Weber K. (1981). Heterogeneity of intermediate filament expression in vascular smooth muscle: a gradient in desmin positive cells from the rat aortic arch to the level of the arteria iliaca communis. Differentiation 20, 196-202.
79. Owens G.K., Vernon S.M. and Madsen C.S. (1996). Molecular regulation of smooth muscle differentiation. J. Hypertens. 14, S55-64.
80. Park F., Mattson D.L., Roberts L.A. and Cowley A.W. (1997). Evidence for the presence of smooth muscle α-actin within pericytes of the renal medulla. Am. J. Physiol. 273, R1742-R1748.
81. Pittet B., Rubbia-Brandt L., Desmoulière A., Sappino A.P., Roggero P., Guerret S., Grimaud J.A., Lacher R., Montandon D. and Gabbiani G. (1994). Action of γ-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast. Reconstr. Surg. 93, 1224-1235.
82. Qu G., Yan H. and Strauch A.R. (1997). Actin isoform utilization during differentiation and remodeling of BC3H1 myogenic cells. J. Cell. Biochem. 67, 514-527.
83. Raats J.M.H. and Bloemendal H. (1992). The role of protein domains in the assembly process of intermediate filaments. Progr. Nucleic Acid Res. Mol. Biol. 43, 67-86.
84. Riser B.L., Cortes P., Zhao X., Bernstein J., Dumler F. and Narins R.G. (1992). Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J. Clin. Invest. 90, 1932-1943.
85. Roberts I.S., Burrows C., Shanks J.H., Venning M. and McWilliam L.J. (1997). Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J. Clin. Pathol. 50, 123-127.
86. Rønnov-Jessen L. and Petersen O.W. (1996). A function for filamentous α-smooth muscle actin: retardation of motility in fibroblasts. J. Cell. Biol. 134, 165-172.
87. Ross M.H. and Romrell L.J. (1989). Urinary system. In: Histology, 2nd edition. Ross M.H. and Romrell L.J. (eds). Williams & Wilkins, Baltimore, pp 527-561.
88. Rubbia-Brandt L., Sappino A.P. and Gabbiani G. (1991). Locally applied GM-CSF induces the accumulation of α-smooth muscle actin containing myofibroblasts. Virchows Arch. (B) 60, 73-82.
89. Rubenstein P.A. (1990). The functional importance of multiple actin isoforms. Bioessays 12, 309-315.
90. Sappino S.P., Schürch W. and Gabbiani G. (1990). Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab. Invest. 63, 144-161.
91. Schevzov G., Lloyd C. and Gunning P. (1992). High level expression of transfected beta-and gamma-actin genes differentially impacts on myoblast cytoarchitecture. J. Cell Biol. 117, 775-785.
92. Schiaffino S. and Reggiani C. (1996). Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol. Rev. 76, 371-423.
93. Schlondorff D. (1987). The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J. 1, 272-281.
94. Schmitt-Gräff A., Desmoulière A. and Gabbiani G. (1994). Heterogeneity of myofibroblast phenotypic features: An example of of fibroblastic cell plasticity. Virchows Arch. 425, 3-24.
95. Schürch W., Seemayer T. and Gabbiani G. (1992). Myofibroblast. In: Histology for pathologists. Sternberg S.S. (ed). Raven Press. New York. pp 109-144.
96. Schürch W., Seemayer T. and Gabbiani G. (1998). The myofibroblast. A quarter century after its discovery. Am. J. Surg. Pathol. 22, 141-147.
97. Serini G. and Gabbiani G. (1996). Modulation of α-smooth muscle actin expression in fibroblasts by transforming growth factor-β isoforms: an in vivo and in vitro study. Wound Rep. Reg. 4, 278-187.
98. Serini G., Bochaton-Piallat M.L., Ropraz P., Geinoz A., Borsi L., Zardi L. and Gabbiani G. (1998). The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J. Cell Biol. 142, 873-881.
99. Sheterline P. and Sparrow J. C. (1994). Actin. Protein Profile. 1, 1-121.
100. Shimizu A., Kitamura H., Masuda Y., Ishizaki M., Sugisaki Y. and Yamanaka N. (1995). Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int. 47, 114-121.
101. Singer I.I., Kawka D., Kazakis D.M. and Clark R.A.F. (1984). In vivo codistribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J. Cell Biol. 98, 2091-2106.
102. Singhal P.C., Scharschmidt L., Gibbons N. and Hays R.M. (1986). Contraction and relaxation of cultured mesangial cells on a silicone rubber surface. Kidney Int. 30, 862-873.
103. Skalli O., Ropraz P., Trzeciak A., Benzonana G., Gillessen D. and Gabbiani G. (1986). A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 103, 2787-2796.
104. Skalli O., Schürch W., Seemayer T.A., Lagacé R., Montandon D., Pittet B. and Gabbiani G. (1989). Myofibroblasts from diverse pathological settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab. Invest. 60, 275-285.
105. Steinman R.M. (1991). The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-296.
106. Striker L.M., Killen P.D., Chi E. and Striker G.E. (1984). The composition of glomerulosclerosis. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab. Invest. 51, 181-192.
107. Tang W.W., Ulich T.R., Lacey D.L., Hill D.C., Qi M., Kaufman S.A., Van G.Y., Tarpley J.E. and Yee U.S. (1996). Platelet derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am. J. Pathol. 148, 1169-1180.
108. Tang W.W., Van G.Y. and Qi M. (1997). Myofibroblast and alpha 1 (III) collagen expression in experimental tubulointerstitial nephritis. Kidney Int. 51, 926-931.
109. Tsukada T., McNutt M.A., Ross R. and Gown A.M. (1987). HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. Am. J. Pathol. 127, 389-402.
110. Vandekerckhove J. and Weber K. (1978). Mammalian cytoplasmic actins are the products of at least two genes and differ in primary structure in at least 25 identified positions from skeletal muscle actins. Proc. Natl. Acad. Sci. USA 75, 1106-1110.
111. vonArx P., Bantle S., Soldati T. and Perriard J.C. (1995). Dominant negative effect of cytoplasmic actin isoproteins on cardiomyocyte cytoarchitecture and function. J. Cell Biol. 131, 1759-1773.
112. Vyalov S., Desmoulière A. and Gabbiani G. (1993). GM-CSF-induced granulation tissue formation: relationships between macrophage and myofibroblast accumulation. Virchows Arch. (B) 63, 231-239.
113. White S.L. and Low R.B. (1996). Identification of promoter elements involved in cell-specific regulation of rat smooth muscle myosin heavy chain gene transcription. J. Biol. Chem. 271, 15008-150017.
114. Wiggins R.C., Goyal M., Merritt S.E. and Killen P.D. (1993). Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit: a cellular source for interstitial collagen synthesis in inflammatory renal disease. Lab. Invest. 68, 557-565.
115. Wolf G., Haberstroh U. and Neilson E.G. (1992). Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am. J. Pathol. 140, 95-107.
116. Zhang K., Rekhter M.D., Gordon D., Phan S.H. (1994). Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145, 114-125.
117. Ziyadeh F.N. (1996). Significance of tubulointerstitial change in diabetic renal disease. Kidney Int. 49, S10-S13.